Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

A catheter-based approach after fibrinolysis is recommended if fibrinolysis is likely to be successful in patients with acute ST-elevation myocardial infarction. We designed a 2x2 randomized, open-label, multicenter trial to evaluate the efficacy and safety of the paclitaxel-eluting stent and tirofiban administered after fibrinolysis but before catheterization to optimize the results of this reperfusion strategy.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Circ Cardiovasc Interv

Title: Circulation. Cardiovascular interventions

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1941-7632

ISSN (Print): 1941-7640

Publication date (Electronic): Aug 2010

Volume: 3

Issue: 4

Affiliations

[1 ] Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Article

Publisher Item ID: 3/4/297

DOI: 10.1161/CIRCINTERVENTIONS.109.920868

PubMed ID: 20716757

SO-VID: d8040df7-211f-434e-a3c5-a50e74a0ef35

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 4

See all cited by